Literature DB >> 8625098

Conditional survival of 56,268 patients with breast cancer.

D E Henson1, L A Ries, M T Carriaga.   

Abstract

BACKGROUND: Survival rates calculated from the date of diagnosis may not be predictive of future outcome for patients who have already survived several years after diagnosis. Conditional survival rates are more informative clinically because they take into account survival after diagnosis.
METHODS: Conditional relative survival rates were calculated by the life-table method using data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
RESULTS: Survival rates up to 8 years for patients having survived 1, 2, 3, 4 or 5 years after diagnosis are presented by stage of disease for 56,268 women who were diagnosed as having invasive breast cancer from 1983 to 1987.
CONCLUSIONS: Women with Stage IV breast cancer had a better survival as they moved further in time from their diagnosis. Survival rates did not improve for those with Stage I and II disease regardless of the number of years they survived after diagnosis.

Entities:  

Mesh:

Year:  1995        PMID: 8625098     DOI: 10.1002/1097-0142(19950715)76:2<237::aid-cncr2820760213>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.

Authors:  Skye C Mayo; Hari Nathan; John L Cameron; Kelly Olino; Barish H Edil; Joseph M Herman; Kenzo Hirose; Richard D Schulick; Michael A Choti; Christopher L Wolfgang; Timothy M Pawlik
Journal:  Cancer       Date:  2011-09-20       Impact factor: 6.860

2.  Conditional survival in gastric cancer: a SEER database analysis.

Authors:  Samuel J Wang; Rachel Emery; Clifton D Fuller; Jong-Sung Kim; Dean F Sittig; Charles R Thomas
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

3.  Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.

Authors:  Lauren C Harshman; Wanling Xie; Georg A Bjarnason; Jennifer J Knox; Mary MacKenzie; Lori Wood; Sandy Srinivas; Ulka N Vaishampayan; Min-Han Tan; Sun-Young Rha; Frede Donskov; Neeraj Agarwal; Christian Kollmannsberger; Scott North; Brian I Rini; Daniel Y C Heng; Toni K Choueiri
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

4.  Conditional survival of all primary brain tumor patients by age, behavior, and histology.

Authors:  Kimberly R Porter; Bridget J McCarthy; Michael L Berbaum; Faith G Davis
Journal:  Neuroepidemiology       Date:  2011-06-16       Impact factor: 3.282

5.  Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study.

Authors:  Nadia D Ali; Kristen Donohue; Shadi Zandieh; Chunxia Chen; Dirk Moore; Elizabeth Poplin; Mihir M Shah; John Nosher; Bin Gui; Salma K Jabbour; Kristen Spencer; Darren R Carpizo
Journal:  Am J Clin Oncol       Date:  2019-06       Impact factor: 2.339

6.  Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.

Authors:  Francesco Alessandro Mistretta; Carlotta Palumbo; Sophie Knipper; Elio Mazzone; Angela Pecoraro; Zhe Tian; Gennaro Musi; Paul Perrotte; Emanuele Montanari; Shahrokh F Shariat; Fred Saad; Alberto Briganti; Ottavio de Cobelli; Pierre I Karakiewicz
Journal:  World J Urol       Date:  2019-07-11       Impact factor: 4.226

7.  An interactive tool for individualized estimation of conditional survival in rectal cancer.

Authors:  Samuel J Wang; Amanda R Wissel; Join Y Luh; C David Fuller; Jayashree Kalpathy-Cramer; Charles R Thomas
Journal:  Ann Surg Oncol       Date:  2011-01-05       Impact factor: 5.344

8.  Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability.

Authors:  Yuhree Kim; Georgios A Margonis; Jason D Prescott; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

9.  Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.

Authors:  Johan L Dikken; Raymond E Baser; Mithat Gonen; Michael W Kattan; Manish A Shah; Marcel Verheij; Cornelis J H van de Velde; Murray F Brennan; Daniel G Coit
Journal:  Ann Surg Oncol       Date:  2012-11-10       Impact factor: 5.344

10.  Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Elena Panettieri; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2019-05-02       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.